menu
    • menu

    Company profile for Antiverse

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We use machine learning to optimise and develop the current drug discovery process. Our world-first computational technique means we can discover new antibodies, faster and better. Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Antiverseunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Cardiff, Wales GB
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.antiverse.io/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/antiverse/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Antiverse Secures $9.3M To Boost AI Drug Discovery
    Antiverse Secures $9.3M To Boost AI Drug Discovery

    04 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-04/innovation-investment-capital-and-development-bank-of-wales-back-antiverse-to-accelerate-ai-driven-drug-discovery-in-93-million-series-a-fund-round

    PHARMIWEB
    04 Mar 2026
    Share Share
    Antiverse Raises $9.3M Series A for Antibody Drug Discovery
    Antiverse Raises $9.3M Series A for Antibody Drug Discovery

    03 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260303630753/en/Antiverse-Raises-%249.3M-Series-A-to-Develop-Antibodies-for-Undruggable-Disease-Targets-and-Announces-Research-Agreement-with-the-Cystic-Fibrosis-Foundation

    BUSINESSWIRE
    03 Mar 2026
    Share Share
    Antiverse Raises 3.5M To Advance AI Antibody Design Platform
    Antiverse Raises 3.5M To Advance AI Antibody Design Platform

    15 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241015364078/en

    BUSINESSWIRE
    15 Oct 2024
    Share Share
    Antiverse and GlobalBio, Inc. Extend Collaboration
    Antiverse and GlobalBio, Inc. Extend Collaboration

    16 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231016924448/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share
    Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification
    Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification

    02 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230301005550/en

    BUSINESSWIRE
    02 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search